Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F88MV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,838
Award facts
- Contract value 100% obligated
- $28,838.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $28.8K delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen auto-injectors on January 15, 2026, with completion targeted for January 16, 2026. This is a firm fixed-price, non-set-aside contract with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99M through December 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare systems globally.
AmerisourceBergen, one of the nation's largest pharmaceutical distributors, continues to fulfill critical medical supply needs for the Department of Defense through its comprehensive IDC vehicle. Cosentyx, a specialty biologic medication used primarily for autoimmune conditions, reflects the contractor's capability to deliver brand-name specialty pharmaceuticals across multiple therapeutic domains to support military treatment facilities and veteran healthcare programs worldwide. The short completion window indicates this delivery order addresses an immediate procurement need within the DLA medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F88MV?
SPE2DR26F88MV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F88MV worth?
The government has obligated $28,838 on SPE2DR26F88MV.
Is contract SPE2DR26F88MV an order under another contract?
Yes. SPE2DR26F88MV is a delivery order under SPE2DR25D3010, an indefinite delivery contract.
Was contract SPE2DR26F88MV competed?
The extent of competition for SPE2DR26F88MV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award